Filing Details
- Accession Number:
- 0000899243-22-036080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-16 21:53:57
- Reporting Period:
- 2022-11-14
- Accepted Time:
- 2022-11-16 21:53:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
742112 | Invacare Corp | IVC | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 952680965 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1535144 | H Steven Rosen | 25101 Chagrin Boulevard, Suite 350 Cleveland OH 44122 | Yes | No | Yes | Yes | |
1933086 | Azurite Management Llc | 25101 Chagrin Boulevard, Suite 350 Cleveland OH 44122 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Disposition | 2022-11-14 | 60,480 | $0.50 | 3,886,078 | No | 4 | S | Indirect | As sole manager of Azurite Management LLC |
Common Shares, No Par Value | Disposition | 2022-11-15 | 78,025 | $0.50 | 3,808,053 | No | 4 | S | Indirect | As sole manager of Azurite Management LLC |
Common Shares, No Par Value | Disposition | 2022-11-16 | 20,000 | $0.49 | 3,788,053 | No | 4 | S | Indirect | As sole manager of Azurite Management LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | As sole manager of Azurite Management LLC |
No | 4 | S | Indirect | As sole manager of Azurite Management LLC |
No | 4 | S | Indirect | As sole manager of Azurite Management LLC |
Footnotes
- The price reported in column 4 is a weighted average price. These common shares, no par value (the "Common Shares"), were sold in multiple transactions at prices ranging from $0.510 to $0.517, inclusive. The Reporting Persons undertake to provide to Invacare Corporation (the "Issuer"), any securityholder of the Issuer or the staff of the Securities and Exchange Commission ("SEC Staff"), upon request, full information regarding the number of shares sold at each price within the range specified herein.
- The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.500 to $0.505, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
- The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.490 to $0.493, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
- Azurite Management LLC ("Azurite") is the owner of record of all such Common Shares. Mr. Rosen, in his capacity as the sole manager of Azurite, has the ability to indirectly control the decisions of Azurite regarding the vote and disposition of securities held by Azurite, and as such may be deemed to have indirect beneficial ownership of the Common Shares held by Azurite. The Reporting Persons disclaim beneficial ownership of the Common Shares owned by Azurite, except to the extent of his pecuniary interest therein.
- This Form 4 is being filed as a result of sales of Common Shares by Azurite. The sales were effected at prices below the prices of the purchases reported in the Form 4s filed by the Reporting Persons on June 7, 2022 (as amended on June 8, 2022) and June 27, 2022, such that there is no profit for purposes of Section 16(b) and the rules promulgated thereunder.